Low-dose intermittent interferon-alpha therapy for HCV-related liver cirrhosis after curative treatment of hepatocellular carcinoma

doi:10.3748/wjg.v13.i39.5188

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 39

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2239)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series, Tables (1-1) series.

Item

Count

PDF

277

HTML

1669

Figures (1-6)

162

Tables (1-1)

131

Sum=2239

Oct 21, 2007 (publication date) through Apr 19, 2024

Times Cited of This Article

Times Cited (21)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Viral Hepatitis

World J Gastroenterol. Oct 21, 2007; 13(39): 5188-5195
Published online Oct 21, 2007. doi: 10.3748/wjg.v13.i39.5188

Full Size Figure Download Figure

Figure 4 Effect of IFN therapy after curative treatment of HCC on Child-Pugh scores. IFN-treated patients were less likely to show deterioration of hepatic function. The average scores of Child-Pugh of the IFN group were significantly better preserved than the non-IFN group (P = 0.0008).

Citation: Jeong S, Aikata H, Katamura Y, Azakami T, Kawaoka T, Saneto H, Uka K, Mori N, Takaki S, Kodama H, Waki K, Imamura M, Shirakawa H, Kawakami Y, Takahashi S, Chayama K. Low-dose intermittent interferon-alpha therapy for HCV-related liver cirrhosis after curative treatment of hepatocellular carcinoma. World J Gastroenterol 2007; 13(39): 5188-5195
URL: https://www.wjgnet.com/1007-9327/full/v13/i39/5188.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i39.5188